| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |